Search results
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 1 day agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 days agoPfizer's Chief Development Officer Roger Dansey said in a statement. CAR-T drugs are developed using...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 5 days agoAfter a median follow-up time of 112 days — roughly three to four months — the shot proved 83.7% ...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 5 days agoModerna's vaccine was approved for the prevention of RSV-associated lower respiratory tract disease...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 1 day agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
The Rocky Road to Safe, Effective Rotavirus Vaccines
MedPage Today· 6 days agoThe development of a safe, effective rotavirus vaccine was a major milestone in reducing hospitalizations and deaths from the virus in children around...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 5 days agovaccine in partnership with Merck. The shot prompts an immune response against a patient's own tumor...
Thousands of cancer patients to trial personalised vaccines
BBC via Yahoo News· 6 days agoAmanda Pritchard, NHS England chief executive, said: “Seeing Elliot receive his first treatment as...
The chicken and egg problem of fighting another flu pandemic
Arkansas Advocate via Yahoo News· 3 days agoThis article first appeared on KFF Health News and is reprinted here under a Creative Commons...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.